Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A deal has been struck to let the NHS offer children an expensive new cancer therapy that has been called the most exciting treatment advance for decades.
CAR-T is a cutting-edge treatment for aggressive leukaemia when other drugs have failed but usually costs hundreds of thousands of pounds per patient.
NHS England boss Simon Stevens says a fair and affordable price has been reached with manufacturer Novartis.
Hospitals could start giving it to a small number of children within weeks.
The first three NHS hospitals to apply to use the CAR-T (chimeric antigen receptor T-cell) therapy are in London, Manchester and Newcastle.
https://www.bbc.co.uk/news/health-45407514
CAR-T is a cutting-edge treatment for aggressive leukaemia when other drugs have failed but usually costs hundreds of thousands of pounds per patient.
NHS England boss Simon Stevens says a fair and affordable price has been reached with manufacturer Novartis.
Hospitals could start giving it to a small number of children within weeks.
The first three NHS hospitals to apply to use the CAR-T (chimeric antigen receptor T-cell) therapy are in London, Manchester and Newcastle.
https://www.bbc.co.uk/news/health-45407514